HishamWehbeMD(He/Him)

Internal Medicine • Cleveland, OH

Gastroenterology

Fellow

Join to view full profile

Dr. Wehbe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wehbe's full profile

Already have an account?

Office
9500 Euclid Avenue
JJ24
Cleveland, OH 44113

Summary

Gastroenterology Fellow at the Cleveland Clinic Foundation-Ohio

Education & Training

Indiana University School of MedicineChief Residency, Internal Medicine, 2023 - 2024
Indiana University School of MedicineResidency, Internal Medicine, 2020 - 2023
American University of Beirut Faculty of MedicineClass of 2019
American Univeristy of BeirutBS, Biology, High Distinction, 2012 - 2015

Certifications & Licensure

OH State Medical License 2024 - 2027
IN State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Alpha Omega Alpha Honor Medical Society 2019
ALMA Award 2019
Diana Tamari Sabbagh Scholar Award 2018

Publications & Presentations

PubMed

9 citations
Selective Androgen Receptor Modulators: An Emerging Liver Toxin.
Haseeb Mohideen, Hafsa Hussain, Dushyant Singh Dahiya, Hisham Wehbe
Journal of Clinical and Translational Hepatology. 2023-02-28
2 citations
Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab:
Hisham Wehbe, Maria Kozah, Salwa A Koubaissi
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine. 2021-07-31
2 citations
Comparative Risks of Post-ERCP Adverse Events in Patients with Asymptomatic and Symptomatic Choledocholithiasis: A Systematic Review and Meta-Analysis.
Itegbemie Obaitan, Mouhand F H Mohamed, Azizullah Beran, Michael Rosenheck, Elvis T Obomanu
Digestive Diseases and Sciences. 2024-05-01

Journal Articles

Selective Androgen Receptor Modulators: An Emerging Liver Toxin
Haseeb Mohideen,Hafsa Hussain, Dushyant Singh Dahiya and Hisham Wehbe, Journal of Clinical and Translational Hepatology, 2/28/2023
Lung Adenocarcinoma With Paraneoplastic Hyper-eosinophilia Not Responding To Pembrolizumab
Wehbe,H.,Kozah M.,Koubaisse, S., Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
SuPAR, a potential inflammatory mediator in psoriasis pathogenesis
Lamia Hamieh, Hisham Wehbe, Mazen Kurban, Clinical and Experimental Pharmacology and Physiology.

Abstracts/Posters

Should the Gallbladder be Empirically Removed at Time of Intestinal Resection in Inflammatory Bowel Disease Patients?
Walaa Mahmoud, MD1, Hisham Wehbe, MD 1, Walid Hout, MD 2, Fadi F. Francis, MD 1, Carla Abu-Fadel, MD 3, Samer Doughan, MD 2, Hani Tamim, PhD 4, David G. Binion, MD 5, ..., Advances in IBD, 10/23/2020
Description of Outcomes of Inflammatory Bowel Disease Patients with Granuloma on Histology: A Single-Center Experience
Hisham Wehbe,Mohammad Hosni, Hani Tamim, David G. Binion, Jana G. Hashash, Advances in Inflammatory Bowel Diseases, Orlando, FL

Other Languages

Arabic